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A B S T R A C T
Objectives: In this study, we document the clinical characteristics and investigated risk factors for
uncomplicated and severe forms of EV-A71 disease in Cambodian children.
Methods: From March to July 2014 inclusive, all patients with suspicion of EV-A71 infection presenting to
Kantha Bopha Hospitals in Phnom Penh and Siem Reap and confirmed by the Virology Unit at the Institut
Pasteur du Cambodge were prospectively enrolled in this study. Throat swabs, rectal swabs and serum
samples were collected from all consecutive patients with suspected EV-A71 infection. In addition, CSF
was also collected from patients with suspected EV-A71 associated encephalitis. A total of 122 patients
(29 with uncomplicated disease and 93 with severe disease) with confirmed EV-A71 infection with all
available demographic and clinical data for clinical classification and further analysis were included in
the study.
Results: In this prospective EV-A71 study in Cambodia, we confirmed the previously reported association
of male gender and absence of mouth or skin lesions with severe disease. We also highlighted the strong
association of neutrophils in blood, but also in CSF in patients with pulmonary oedema. More
importantly, we identified new putative nutrition-related risk factors for severe disease.
Conclusions: EV-A71 is an important cause of encephalitis in the Asia-Pacific region. Further studies to
determine the risk factors associated with severe EV-A71 disease are needed.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).is one of the most common aetiologies of hand, foot and mouth
disease (HFMD) in children. EV-A71 associated disease is usually
mild with children typically recovering within 4-6 days. However,
the virus has been associated with fulminant disease during large
outbreaks in many parts of the World, including Bulgaria
(Shindarov et al., 1979), Hungary (Nagy et al., 1982), Malaysia
(Chan et al., 2000), Taiwan (Huang et al., 1999), Singapore (Chong
et al., 2003), and China (Li et al., 2012; Liu et al., 2014; Huang et al.,
2014). A meta-analysis has estimated case-fatality rates for
hospitalized cases of HFMD associated with EV-A71 at 1.7% (Zhao
et al., 2015).
In 2012, an outbreak of EV-A71 in Cambodia associated with
cardiovascular collapse and pulmonary oedema gained interna-
tional attention following the deaths of nearly 100 young childrenciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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EV-A71 epidemic reported in Cambodia, retrospective seroepide-
miological testing showed that there was widespread circulation of
the virus for at least a decade prior to the outbreak (Horwood et al.,
2016). The pathogenetic and epidemiological mechanisms of how
this virus intermittently causes large deadly outbreaks remains
unclear.
We report factors associated with clinical characteristics of
122 Cambodian pediatric patients during an EV-A71 outbreak in
2014. We focus on environmental, clinical and biological risk
factors for severe neurological and/or pulmonary disease associ-
ated with confirmed EV-A71 infection.
Methods
Clinical methods
During an EV-A71 disease outbreak in Cambodia from March to
July 2014 inclusive, all patients with confirmed EV-A71 infection
presenting at either of two Kantha Bopha Hospitals (one in
Cambodia’s southeastern capital Phnom Penh and the other in
Siem Reap in the north-west of the country) were enrolled in the
study. The clinical definitions used throughout the study are listed
in Table 1. Patients with uncomplicated EV-A71 HFMD were
compared to patients with severe forms of infection, including
isolated encephalitis without pulmonary oedema (ECP) and
pulmonary oedema with or without neurological involvement
(PO). Demographic and clinical data were recorded for further
analysis on a case report form (CRF) that was specifically designed
for the study. Clinical outcome was not available for the study and
patients were not followed-up.
Virological methods
Throat swabs, rectal swabs and serum samples were collected
from all patients presenting to Kantha Bopha Hospitals with
suspected EV-A71 infection. In addition, cerebrospinal fluid (CSF)
was also collected from patients with suspected EV-A71 associated
encephalitis. Nucleic acids were extracted from all samples using
the QIAamp Viral RNA Minikit (Qiagen, Hilden, Germany), as
outlined in the manufacturer’s instructions. EV-A71 infections
were detected by testing all clinical samples using an EV-
A71 specific qRT-PCR assay (Khanh et al., 2012) or culture isolation
of EV-A71 from original clinical material in Vero E6 cells. EV-
A71 infection was confirmed if PCR or culture was positive in any of
the tested samples. Severe EV-A71 cases with neurological
symptoms were confirmed by the detection of EV-A71 by qRT-Table 1
Clinical definitions used in this study.
 Suspected EV-A71 infection was defined as an acute illness with either systemic (e.g
infection.
 Confirmed EV-A71 infection was defined as a suspected EV-A71 infection plus the i
throat swab, serum or cerebrospinal fluid sample.
 Uncomplicated Hand Foot Mouth Disease patients (HFMD) were defined as patients 
of HFMD and without neurological symptoms.
 Skin lesions were defined as vesiculo-papular or maculo-papular rash (mostly pre
 Mouth lesions were defined as oral ulceration usually observed on anterior tonsill
 Neurological symptoms were defined as Glasgow Coma Scale (GCS) score (or modifi
weakness.
 Neurological involvement was defined as neurological symptoms and/or CSF white c
magnetic resonance imaging) suggestive of encephalitis.
 Pulmonary oedema was defined as respiratory symptoms and bilateral alveolar co
 Encephalitis patients (ECP) were defined as patients with neurological involvemen
 Pulmonary oedema patients (PO) were patients with pulmonary oedema with or w
 ECP and PO were termed severe patients.PCR or culture from CSF or blood; and/or detection of EV-A71 in
both throat and rectal swabs, as previously recommended (Jain
et al., 2014). Laboratory test results were integrated in the light of
clinical findings to provide diagnosis (Figure 1).
EV-A71 phylogenetic analysis
EV-A71 isolates were randomly selected from throughout the
outbreak period for sequence analysis of the VP-1 region.
Amplicons (500 bp) of the VP-1 region were produced using
RT-PCR (Nix et al., 2006) for EV-A71 isolates associated with
uncomplicated HFMD (n = 6) and severe EV-A71 infection (n = 5).
The amplicons were sequenced at a commercial facility (Macrogen,
South Korea) by Sanger method. Contiguous sequences were
assembled using CLC Workbench (CLC bio) and compared to
representative EV-A71 sequences downloaded from the NCBI
GenBank database. Neighbour-joining trees were constructed with
MEGA5 (Tamura et al., 2011) and bootstrap values were calculated
and expressed as a percentage from 1,000 replicates.
Data collection and analysis
Data was collected at the bedside using a specifically designed
CRF that was focused on socio-demographic variables as well as
general and neurological clinical findings. Demographic and
clinical data were collected for age, sex, hospital of inclusion,
province, fever, peak body temperature, and neurological and extra
neurological symptoms and signs at presentation. While in
hospital, bodyweight, heart rate, blood pressure, body tempera-
ture, mental status, general and neurological examination and
treatment were assessed. Weight-for-age z scores were computed
for all patients and compared with the World Health Organization
child growth standards (www.who.int/childgrowth).
Laboratory data including blood-cell count and differentiated
white-blood-cell count, haemoglobin, platelet count, creatinin,
liver enzymes, and blood glucose were collected from all patients.
Cell count, differentiated cell count, glucose, and protein were also
collected from the cerebrospinal fluid of patients with neurological
symptoms. Chest radiography, brain computed tomography, and
brain magnetic resonance imaging scans were reviewed by
radiologists and recorded. Data was entered using standardized
paper forms and then exported into an Excel1 spreadsheet.
Statistical analysis
Data was analysed with the SPSS statistical package (Version
22; IBM Corp. Armonk, NY: USA). The Student’s t-test for., fever), respiratory, neurological or skin signs and symptoms suggestive of viral
solation of EV-A71 virus or molecular detection of EV-A71 RNA in a rectal swab,
with a confirmed viral infection presenting with the classical signs and symptoms
sent over the hands, soles and/or buttocks).
ar pillars, soft palate, buccal mucosa, or uvula.
ed GCS in less than 2 years old) less than 14 or clinical rhombencephalitis or limb
ell count >5/mm3 and/or abnormal brain imaging (computed tomography scan or
ngestion on chest radiography.
t without pulmonary oedema.
ithout neurological involvement.
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Figure 1. Flow chart showing enrolment into the study.
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used for categorical data. Fisher’s exact test was used adjunctively
if the expected values were less than 5. Bonferroni correction was
used as a correction for multiple comparison analysis. Binary
logistic regression analysis was used to examine the multivariate-
adjusted odds ratios for risk factors that were significant (p value of
less than 0.05) in the univariate analysis.
Factors significantly associated with ECP or PO patients in the
univariate analysis were included in the multivariate analysis.
Forward stepwise regression was used for identifying the optimum
variable for the model. A p value of less than 0.05 was considered
statistically significant.
Ethics
Ethical clearance was obtained from the Cambodian National
Ethics Committee for Human Research before testing commenced.
All parents/guardians of sick children who participated in this
study provided written informed consent; and clinical CRFs were
anonymized to protect the identity of patients.
Results
Patient characteristics
During the five-month period, 148 patients with laboratory
confirmed EV-A71 infection were enrolled. Of these 117 (79.1%)
patients were recruited in Phnom Penh and 31 (20.9%) were
recruited in Siem Reap hospital sites. The recruited patients
originated from 17 out of 25 of Cambodia’s provinces, mainly from
the three most populated provinces in Cambodia: Phnom Penh
(25.9%), Kandal (14.2%) and Kampong Cham (12.2%).
The mean age at onset of disease was 28.6 months (range
5 months to 15 years; median 20 months). The majority (n = 133;
90%) of the patients included in the study were less than five yearsold. The male:female ratio was 1.5:1. Patients had a low median
weight for age adjusted z score of 1.11 (range 4.05 to 2.40; mean
0.94; IQR 2.39) (Table 2), compared with the World Health
Organization child growth standards.
A total of 122 (82%) patients were enrolled in the study with all
available data for clinical classification and further analysis. The
median time to hospitalization for these children was two days
(range from 0 to 31 days; mean 3.2 days). Twenty-nine (19.6%)
patients were classified as uncomplicated HFMD patients and
93 patients were classified with severe EV-A71 disease, including
35 (23.6%) who had ECP and 58 (39.2%) with PO (with or without
neurological involvement in 52 and 6 cases respectively).
Overall, 84 (56.8%) patients had either mouth or skin lesions on
admissionexamination.Typicalclinicalcoursebeganwithcoughand
fever 3.2 1.4 days on average before admission. Skin and mouth
lesionsthenappeared2.4  0.82 daysbeforeadmission,andinsevere
cases dyspnea and vomiting would begin 2.2  1.23 days before
admission, followed by coma and convulsions 1.6  0.99 days before
admission. Lumbar puncture was performed in all ECP patients, in 48
(82.8%) PO patients and in 1 (3.4%) HFMD patient. Chest X-ray was
available for 117 (79.1%) patients. Seven (4.7%) patients underwent a
brain CT scan and 36 (24.4%) patients had a brain MRI.
Overall, rectal swabs had the highest detection rate of EV-
A71 by PCR or culture (100/122; 82.0%), followed by throat swabs
(95/122; 77.9%), serum samples (59/122; 48.4%) and CSF samples
(26/93; 28.0%) (Table 3).
Comparison of HFMD and ECP patients
By definition, ECP patients had a higher rate of neurological
signs and symptoms (headache, limb weakness and convulsion),
abnormal neurological examination (lower mean GCS and higher
rate of brainstem clinical involvement) and MRI brainstem
involvement. In univariate analysis, compared to HFMD cases,
ECP patients were significantly more often male, and more often
Table 2
Statistical analyses of the demographic and clinical characteristics associated with uncomplicated and severe cases of enterovirus 71 infections.
Characteristics HFMD n = 29 Na Encephalitis (ECP)
n = 35
Na Pulmonary oedema (PO)
n = 58
Na p value HFMD vs ECP p value ECP vs PO
Demographic
Male gender 17 (58.6) 10 (28.6) 18 (31) 0.015 0.802
Age, months 21 [12–72] 29 20 [5–168] 35 19 [5–96] 58 0.962 0.221
Province 11 (37.9) 5 (14.3) 10 (17.2) 0.003 0.052
Phnom Penh 7 (24.1) 2 (5.7) 9 (15.5)
Kandal 0 (0) 6 (17.1) 1 (1.7)
Battambang 11 (37.9) 22 (62.9) 37 (63.8)
Other 78.6 [5.8–231] 29 108 [2.90–302] 35 86 [2.9–315] 57 0.022 0.734
Mean distance to hospital, Km 2 [0–3] 18 3 [1–7] 28 3 [0–31] 49 0.006 0.690
History of disease
Fever 23 (79.3) 34 (97.1) 58 (100) 0.023 0.196
Duration of fever 2 [2–4] 22 3 [1–16] 33 3 [1–10] 53 0.010 0.329
Cough 4 (13.8) 15 (42.9) 32 (55.2) 0.011 0.25
Sputum 0 (0) 2 (5.7) 14 (24.1) 0.191 0.023
Dyspnea 2 (6.9) 8 (22.9) 46 (79.3) 0.080 <0.001
Vomiting 3 (10.3) 21 (60) 44 (75.9) <0.001 0.106
Abdominal pain 0 (0) 4 (11.4) 10 (17.2) 0.060 0.448
Diarrhea 0 (0) 6 (17.1) 10 (17.2) 0.019 0.99
Mouth ulcer 26 (89.7) 11 (31.4) 15 (25.9) <0.001 0.562
Duration of mouth lesions 2 [1–3] 26 3 [2–5] 11 2 [1–4] 11 0.043 0.401
Skin lesion 28 (96.6) 16 (45.7) 13 (22.4) <0.001 0.019
Duration of skin lesion 2 [1–3] 28 3 [1–6] 16 2.5 [2–4] 10 0.028 0.623
Headache 1 (3.4) 10 (28.6) 13 (22.4) 0.008 0.505
Neck stiffness 0 (0) 3 (8.6) 3 (5.2) 0.106 0.518
Limb weakness 0 (0) 8 (22.9) 9 (15.5) 0.006 0.375
Seizure 0 (0) 7 (20) 34 (58.6) 0.011 <0.001
Coma 0 (0) 4 (11.4) 16 (27.6) 0.060 0.066
Examination findings
Weight, Kg 11 [7.5–21] 29 9.6 [7–30] 34 10 [6–20] 58 0.284 0.390
Weight Age adjusted z score 0.5 [2.87–
1.58]
28 1.51 [3.25–0.81] 29 1.26 [4.05–1.96] 53 0.004 0.597
Temperature, C 37 [36.5–40] 29 38.3 [36.5–40] 34 38.3 [35–40] 58 0.007 0.828
Pulse, bpm 120 [108–180] 29 124 [100–160] 32 140 [60–190] 44 0.154 <0.001
Respiratory rate per min 40 [32–70] 29 40 [30–60] 31 60 [24–120] 43 0.400 <0.001
Glasgow Coma Scale 15 [14–15] 29 15 [3–15] 32 11 [3–15] 55 <0.001 0.015
Oral lesions 27 (93.1) 10 (28.6) 14 (24.1) <0.001 0.636
Skin lesions 28 (96.6) 14 (40) 14 (24.1) <0.001 0.106
Abnormal chest examination 27 (93.1) 30 (90.9) 16 (28.6) 0.752 <0.001
Enlarged liver 0 (0) 5 (14.3) 15 (25.9) 0.058 0.188
Brainstem clinical involvement 0 (0) 6 (19.4) 8 (14.8) 0.013 0.587
Paraplegia 0 (0) 1 (2.9) 7 (12.1) 0.359 0.125
Investigation findings
Haemoglobin, g/dL 11.8 [9.8–13.2] 16 10.5 [7.9–12.9] 35 10.6 [6.4–19.1] 55 0.004 0.497
Mean corpuscular volume, fl 71 [51–80] 17 66 [55–83] 35 66.5 [42–83] 54 0.036 0.762
White cells count, 109 cells/L 11.7 [7.1–22.1] 18 17.4 [6.7–46.8] 35 19.6 [7.1–54.3] 56 0.001 0.029
Neutrophils count, 109 cells/L 5.36 [3.08–13.48] 17 9.51 [0.47–28.22] 35 12.22 [0–35.84] 55 0.003 0.028
Lymphocytes count, 109 cells/L 4.75 [2.62–8.0] 17 4.18 [1.51–16.38] 35 5.06 [0.5–23.80] 55 0.689 0.211
Platelets count, 109 cells/L 336 [162–575] 18 482 [67–743] 35 468 [86–874] 55 0.012 0.970
Creatinine, mmol/L 38.5 [13–97] 18 35 [3.5–75] 35 38.5 [1–105] 52 0.104 0.129
AST, IU/L 37 [25–93] 18 43 [11.4–175] 34 52 [11–365] 53 0.923 0.095
ALT, IU/L 18.5 [15–74] 18 26.5 [11–119] 34 22 [10–549] 54 0.046 0.574
Blood glucose, mmol/L 4.9 [1.3–16] 18 5 [2–14.5] 32 9.1 [1.1–88] 53 0.262 0.000
CSF white cells count, 109 cells/
L
4 [4–4] 1 33 [2–549] 35 61 [2–927] 42 0.333 0.539
CSF lymphocytes, % NA 0 56.5 [32–71] 20 39 [30–68] 22 NA 0.023
CSF neutrophils, % NA 0 44 [29–68] 20 60.5 [32–70] 22 NA 0.037
CSF proteins, g/L NA 0 0.31 [0.12–0.75] 35 0.32 [0.1–14] 40 NA 0.778
CSF glucose, mmol/L 4.4 [4.4–4.4] 1 4 [2–35.2] 35 5.3 [1.75–98] 42 0.722 <0.001
Abnormal chest X Ray 1 (5.6) 2 (5.9) 58 (100) 0.962 <0.001
Abnormal brain CT scan 0 (0) 1 (100) 5 (83.3) NA 0.659
Abnormal brain MRI 0 (0) 20 (100) 14 (93.3) NA 0.241
MRI brainstem involvement 0 (0) 8 (22.9) 5 (8.6) 0.006 0.069
The round brackets contain percentage; the square brackets contain vales range.
NA: not available.
a N: the number of patients with available data.
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Table 3
Virological detection rates of enterovirus 71 from different clinical samples.
Detection Mild disease Severe disease
HFMD (n = 29) ECP (n = 35) PO (n = 58) Total (n = 93)
CSF PCR NA 7 (20.0%) 17 (29.3%) 24 (25.8%)
CSF culture NA 5 (14.3%) 3 (5.2%) 8 (8.6%)
CSF totala 0/1 (0%) 8 (22.9%) 18 (31.0%) 26 (28.0%)
Serum PCR 15 (51.7%) 14 (40.0%) 28 (48.3%) 42 (45.2%)
Serum culture 1 (3.4%) 3 (8.6%) 1 (1.7%) 4 (4.3%)
Serum totala 15 (51.7%) 16 (45.7%) 28 (48.3%) 44 (47.3%)
Throat PCR 25 (86.2%) 25 (71.4%) 45 (77.6%) 70 (75.3%)
Throat culture 10 (34.5%) 7 (20.0%) 20 (34.5%) 27 (29.0%)
Throat totala 25 (86.2%) 25 (71.4%) 45 (77.6%) 70 (75.3%)
Rectal PCR 27 (93.1%) 27 (77.1%) 45 (77.6%) 72 (77.4%)
Rectal culture 11 (37.9%) 7 (20.0%) 15 (25.9%) 22 (23.7%)
Rectal totala 27 (93.1%) 27 (77.1%) 46 (79.3%) 73 (78.5%)
a total values are the number of samples positive by PCR OR culture.
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from home to the hospital. ECP patients also had significantly
lower weight-for-age adjusted z score (1.51 [3.25–0.81] vs 0.5
[2.87–1.58]; p = 0.004) (Table 2).
ECP patients had a longer prodromal phase before admission,
including a higher percentage of fever, cough and digestive
prodromes (diarrhea or vomiting). They also had higher median
fever on examination. They had significantly lower rate of mouth or
skin lesions and, when they appeared, a longer duration of skin or
mouth lesions. ECP patients had lower haemoglobin titers, lower
mean corpuscular volume, higher neutrophil and platelets counts,
and ALT value.
Comparison of ECP and PO patients
By definition, PO patients had higher rate of sputum, dyspnea,
abnormal chest examination or chest X-Ray and higher respiratory
and pulse rates compared to ECP patients (Table 2). Blood pressure
at admission, however, did not differ within groups. Compared to
ECP patients, PO patients were less likely to have skin lesions and
had a higher frequency of neurological signs (lower GCS score and
higher frequency of convulsion). They had higher white cells count,
especially neutrophil count and higher median blood glucose level
(9.1 [1.1–88] mmol/L vs 5 [2–14.5] mmol/L, p = 0.000). PO patients
were also more likely to have elevated PNN counts in CSF. There
was no significant difference in clinical or MRI brainstem
involvement between PO patients with neurological involvement
and ECP patients.
Multivariate analysis
In logistic regression, PNN count (OR = 2.57 CI95[1.25–5.31],
p = 0.011), and haemoglobin titers (OR = 0.181, CI95[0.037–0.881],
p = 0.034) were significantly associated with ECP. Time to hospitali-
zation didn’t reach statistical significance (OR = 3.065, CI95[0.846–
11.11], p = 0.088). Blood PNN count (OR = 2.57 CI95[1.25–5.31],
p = 0.011) and CSF neutrophil differential count (OR = 1.079, CI95
[1.011–1.151], p = 0.021) were significantly associated with PO
patients.Phylogenetic analysis
Sequence comparison and phylogenetic analysis of representa-
tive EV-A71 strains associated with uncomplicated HFMD and
severe cases found no differences in the VP-1 region (Figure 2).
There was no discernible clustering of EV-A71 strains according to
severity of illness. All of the viruses analyzed were EV-A71 C4a
strains, which were previously associated with the 2012 outbreak
in Cambodia. The 2014 viruses clustered closest to EV-A71 strains
associated with the Cambodian EV-A71 epidemic in 2012; and
Vietnamese strains from 2011-2013.
Discussion
In this prospective study, comparative analysis showed uncom-
plicated HFMD and ECP patients differed significantly regarding
gender, province of residence, weight-for-age adjusted z score, time
to admission, fever, mouth and skin lesions, haemoglobin, mean
corpuscular volume, neutrophil and platelets counts. ECP and PO
patients also differed regarding skin lesions, neurological signs,
neutrophil count in blood or CSF and median blood glucose level.
Provinces outside Phnom Penh, distance to hospital reference center,
weight-for-age adjusted z score, haemoglobin, mean corpuscular
volume and thrombocytosis were associated with severe forms of
EV-A71 infection.
Patients experiencing severe EV-A71 infection had a significantly
lower percentage of mouth or skin lesions. In 29 fatal cases of EV-
A71 infections, one of the largest case series previously reported, oral




associated with severe disease (Chong et al., 2003; Ooi et al., 2007).
This association could be simply related to a bias in patient
recruitment. Indeed, by an implicit definition, non-severe symptom-
atic patients included in our study went to hospital because they had
skin or mucosal lesions, whereas patients with neurological or
respiratory symptoms were hospitalized regardless of their derma-
tological status. Furthermore, EV-A71 related rash has been reported
as often subtle and scant, especially in younger patients with natural
tanned skin, and could also have been missed because of delayed




skin or dermatological lesions reflect the host’s ability to mount an
efficient immune response against EV-A71, as reported in other viral
infections, such as parvovirus B19 infection (Bültmann et al., 2004).
Our findings confirm previously reported risk factors for severe
forms of EV-A71 infection, including male gender (Zhang et al.,
2014), delayed time to hospitalization (Fang et al., 2014), high or
prolonged fever (Ooi et al., 2007; Zhang et al., 2014; Ooi et al., 2009;
Chang et al., 1999) and vomiting (Chong et al., 2003; Ooi et al.,
2007; Chang et al., 1999). A clear and well-documented overrep-
resentation of males exists in many infectious diseases, with an
apparent influence of testosterone and X chromosome on immune
responses and disease progression (Libert et al., 2010; Bernin and
Lotter, 2014). However, a recent meta-analysis of 19 studies
investigating the risk factors for severe EV-A71 disease found no
association with gender (Fang et al., 2014).
Our study did not confirm other risk factors for CNS disease
identified following large previous EV-A71 outbreaks. Young age
(Ooi et al., 2007; Zhang et al., 2014; Chang et al., 1999), home care
(Fang et al., 2014) and neurological signs (headache, history of
lethargy, limb weakness) (Zhang et al., 2014; Ooi et al., 2009; Chang
et al.,1999) have been reported. Viral factors such as genogroup (Ooi
Figure 2. Phylogenetic tree based on VP-1 sequences of enterovirus 71 strains, generated in MEGA5 (Ooi et al., 2007). The numbers next to the branches indicate the
percentage of 1000 bootstrap replicates that support each phylogenetic branch. The tree is drawn to scale, with branch lengths measured in the number of substitutions per
site.
~ EV-A71 strains sequenced in the present study associated with severe illness.
4 EV-A71 strains sequenced in the present study associated with uncomplicated illness.
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been studied. Co-infection and antibody responses have not been
shown to be related to severe forms (Ooi et al., 2007; Yang et al.,
2011a). In multivariate meta-analysis, male gender, residing in rural
areas and absence of mouth ulcers at examination were not
significantly associated with severity (Fang et al., 2014).
Our results are conflicting regarding typical CSF in EV-A71 CNS
infection. In one study in children with EV-A71 meningitis, CSF
showed a neutrophil predominance in 64% of cases and >200 WBC/
mm3 in 25% (Goldberg and Weiner, 1981) In a case series of
29 children with EV-A71 fatal infections, lymphocytic predomi-
nance was reported in 11/12 patients with pleiocytosis on lumbar
puncture (Chan et al., 2000). Our results confirm previous findings
on the association between EV-A71 related pulmonary oedema
and high neutrophil count or hyperglycemia (Chang et al.,1999; Lin
et al., 2002) but also highlights the higher rate of neutrophilic CSF
in PO patients and lymphocytic CSF in encephalitis patients .
Interestingly, PO patients in our study did not differ signifi-
cantly in terms of clinical or MRI brainstem lesions or dysauto-
nomic symptoms, compared to ECP patients. Our findings suggest
that PO pathophysiology in Cambodian children may be more
closely related to cytokinic inflammatory cardiac dysfunction
rather than to neurogenic pulmonary oedema.
Our study has important limitations, including the lack of
outcome data for patients. Although many surrogate markers of
malnutrition were identified as putative risk factors for severe
disease, only low haemoglobin titres were independently associated
with encephalitis in multivariate analysis. Lack of power and some
degree of variable colinearity could explain the lack of differences
across groups inmultivariate analysis. Thisstudycontained potential
biases in the recruitment of patients due to the fact that parents of
rural origin are less likely to travel long distances to bring their
children to the hospital for mild disease such as uncomplicated
HFMD, hence the overrepresentation and late presentation of severe
illness among children of rural origin. Indeed, there was a negative
correlation between distance to hospital and GCS on admission
(Pearson 2.56, p = 0.004), suggesting people from remote areas
tend to come to hospital for more severe symptoms. However, there
was no correlation between distance to hospital and weight adjusted
z score (Pearson = 0.06, p = 0.43), suggesting malnutrition may be
an independent key factor for severe disease. In addition, the
significant association between rash and mouth ulcerations with
mild illness may be an artefact due to these factors being included in
the definition for uncomplicated HFMD. Finally, the possibility that
co-infection with other viral pathogens contributed to the clinical
characteristics of children infected with EV-A71 was not explored in
this study. However, previous studies suggest that co-infections with
otherviruses rarelyoccur inEV-A71 associatedencephalitisorHFMD
cases (Le et al., 2010; Sapkal et al., 2009; Yang et al., 2011b).
In this prospective EV-A71 outbreak study in Cambodia, we
confirmed the previously reported association of male gender and
absence of mouth or skin lesions with severe disease. We also
highlighted the strong association of neutrophils in blood but also in
the CSF of patients with pulmonary oedema. More importantly, we
identified new putative malnutrition-related risk factors of severe
disease that warrant further investigations, including a more
detailed analysis of nutritional status.
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